E-LIB Suche - Ergebnisse für: Lambert-Niclot, S

1

EE485 Cost-Effectiveness of a 4 Days-a-Week Triple Therapy ..:

Hejblum, G. ; Daher, S. ; Moulaire, P....
Value in Health. 26 (2023) 12 - p. S144-S145 , 2023

Link: https://doi.org/10.1016/..

2

Emerging resistance mutations in PI-naive patients failing ..:

Lambert-Niclot, S ; Grude, M ; Chaix, M L...
Journal of Antimicrobial Chemotherapy. 73 (2018) 8 - p. 2147-2151 , 2018

Link: https://doi.org/10.1093/..

3

Resistance profile and treatment outcomes in HIV-infected c..:

Fofana, D B ; d'Almeida, M ; Lambert-Niclot, S...
Journal of Antimicrobial Chemotherapy. 73 (2018) 11 - p. 3143-3147 , 2018

Link: https://doi.org/10.1093/..

4

Prevalence and clinical impact of minority resistant varian..:

Nguyen, T ; Fofana, D B ; Lê, M P...
Journal of Antimicrobial Chemotherapy. 73 (2018) 9 - p. 2485-2492 , 2018

Link: https://doi.org/10.1093/..

5

OA3-2 PD-1 blockade in 12 HIV-infected patients with lung c..:

Samri, A. ; Lavolé, A. ; Even, S....
Journal of Virus Eradication. 3 (2017) - p. 3-4 , 2017

Link: https://doi.org/10.1016/..

6

Usefulness of an HIV DNA resistance genotypic test in patie..:

Lambert-Niclot, S. ; Allavena, C. ; Grude, M....
Journal of Antimicrobial Chemotherapy. 71 (2016) 8 - p. 2248-2251 , 2016

Link: https://doi.org/10.1093/..

7

Performance of genotypic algorithms for predicting tropism ..:

Soulié, C. ; Fofana, D.B. ; Boukli, N....
Journal of Clinical Virology. 76 (2016) - p. 51-54 , 2016

Link: https://doi.org/10.1016/..

8

Antiretroviral resistance at virological failure in the NEA..:

Lambert-Niclot, S. ; George, E. C. ; Pozniak, A....
Journal of Antimicrobial Chemotherapy. 71 (2015) 4 - p. 1056-1062 , 2015

Link: https://doi.org/10.1093/..

9

Very early ART resulting in the absence of HIV-1 antibodies..:

Calin, R. ; Fourati, S. ; Schneider, L....
Journal of Antimicrobial Chemotherapy. 70 (2014) 1 - p. 317-319 , 2014

Link: https://doi.org/10.1093/..

10

High level of HIV-1 resistance in patients failing long-ter..:

Fofana, D. B. ; Soulie, C. ; Balde, A....
Journal of Antimicrobial Chemotherapy. 69 (2014) 9 - p. 2531-2535 , 2014

Link: https://doi.org/10.1093/..

11

Genetic barrier for attachment inhibitor BMS-626529 resista..:

Fofana, D. B. ; Charpentier, C. ; Maiga, A. I....
Journal of Antimicrobial Chemotherapy. 70 (2014) 1 - p. 130-135 , 2014

Link: https://doi.org/10.1093/..

12

Rapid plasma viral suppression in naive HIV-infected patien..:

Seang, S. ; Fourati, S. ; Keita, Y....
Journal of Antimicrobial Chemotherapy. 69 (2014) 12 - p. 3356-3359 , 2014

Link: https://doi.org/10.1093/..

13

Genetic barrier to the development of resistance to rilpivi..:

Fofana, D. B. ; Soulie, C. ; Maiga, A. I....
Journal of Antimicrobial Chemotherapy. 68 (2013) 11 - p. 2515-2520 , 2013

Link: https://doi.org/10.1093/..

14

Rilpivirine, emtricitabine and tenofovir resistance in HIV-..:

Lambert-Niclot, S. ; Charpentier, C. ; Storto, A....
Journal of Antimicrobial Chemotherapy. 69 (2013) 4 - p. 1086-1089 , 2013

Link: https://doi.org/10.1093/..

15

Evolution of the K65R, K103N and M184V/I reverse transcript..:

Charpentier, C. ; Lambert-Niclot, S. ; Visseaux, B....
Journal of Antimicrobial Chemotherapy. , 2013

Link: https://doi.org/10.1093/..